Johns Hopkins Medicine

Alzheimer's Disease Research Center

Treatment with Intranasal Insulin to Slow Progression of Mild Alzheimer's Disease

Principal Investigator: Esther Oh, M.D.

The goal of this clinical trial is to determine if treatment with intranasal insulin can delay progression of cognitive decline among individuals with mild Alzheimer's disease.

For more information, contact Sasha Pletnikova at or call 410-550-4969.